Current Practices in NHL Therapy: Focus on Marginal Zone Lymphomas
This information was originally presented on September 21, 2013, at the NCCN 8th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Outline the current standards of care for treatment of the major subtypes of marginal zone lymphomas
Leo I. Gordon, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- 0.50 Participation
- 0.50 Nurse
- 0.50 Pharmacist
- 0.50 Physician